Martin Solleveld

Martin, financial controller, has been involved with Thuja since inception in 2007. He has extensive experience with financial management in general and with venture capital in particular (amongst which ABN Amro Private Equity, AAC Life Sciences, Forbion, V-Bio), as well as biotech companies (for example Pharming, Crucell, Uniqure, ProQR Therapeutics). Martin has been an independent financial manager & consultant since 2004. Before that, Martin worked several years as manager and consultant at Arthur Andersen (predecessor of Deloitte) in the field of business process management and as an auditor at EY.